MPG.eBooks - Search Results

Cover Image

1861

Clinical review report: Crisaborole ointment, 2% (Eucrisa) (Pfizer Canada Inc.) : indication : for topical treatment of mild to moderate atopic dermatitis in patients 2 years of ag...

Published 2019

CADTH

Cover Image

1862

Nociception monitoring for general anesthesia : a review of clinical effectiveness, cost-effectiveness, and guidelines

by Banerjee, Srabani, MacDougall, Danielle
Published 2018

CADTH

Cover Image

1863

Clinical review report: Tafamidis (Vyndaqel) (Pfizer Canada ULC) : indication: for the treatment of adult patients with cardiomyopathy due to transthyretin-mediated amyloidosis, wi...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

1864

Clinical review report: Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi) (Gilead Sciences Canada, Inc.)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

1865

Lifestyle prescriptions : a review of the clinical evidence

Published 2014

Canadian Agency for Drugs and Technologies in Health

Cover Image

1866

Simeprevir (Galexos) (150 mg)

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

1867

Alogliptin (Nesina) for type 2 diabetes mellitus

Published 2015

Canadian Agency for Drugs and Technologies in Health

Cover Image

1868

CADTH Canadian Drug Expert Committee final recommendation: Omalizumab -- resubmission (Xolair -- Novartis Pharmaceuticals Canada Inc.) : indication: asthma

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

1869

Adapted or tailored psychological interventions for treating women with mental illness : a review of clinical effectiveness and guidelines

by Williams, D., Mierzwinski-Urban, Monika
Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

1870

CADTH Canadian Drug Expert Committee final recommendation: Empagliflozin / metformin hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.) : indication : type 2 diabetes mel...

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

1871

Galsulfase (Naglazyme)

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

1872

Pharmacoeconomic review report: Ustekinumab (Stelara/Stelara I.V.) Janssen Inc. : indication: treatment of adult patients with moderately to severely active ulcerative colitis who...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

1873

Tisagenlecleucel for B-Cell acute lymphoblastic leukemia and diffuse large B-Cell lymphoma: Project protocol, implementation and ethics section

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

1874

CADTH Canadian Drug Expert Committee final recommendation: Selexipag (Uptravi -- Actelion Pharmaceuticals Canada Inc.) : Indication: pulmonary arterial hypertension

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

1875

Neurofeedback and biofeedback for mood and anxiety disorders : a review of clinical effectiveness and guidelines

by Banerjee, Srabani, Argáez, Charlene
Published 2017

CADTH

Cover Image

1876

CADTH Canadian drug expert committee recommendation: Latanoprost (Monoprost -- Laboratoires Thea) : indication : glaucoma and ocular hypertension

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

1877

CADTH Canadian Drug Expert Committee recommendation: Migalastat (Galafold -- Amicus therapeutics) : indication : Fabry disease

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

1878

Patient group input submissions: Sapropterin dihydrochloride (Kuvan) for phenylketonuria (PKU)

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

1879

Off-label use of intravenous immunoglobulin for solid organ transplant rejection : a review of clinical effectiveness

by Khangura, Sara, Visintini, Sarah
Published 2018

CADTH

Cover Image

1880

Pharmacoeconomic review report: Cysteamine delayed-release capsules (Procysbi), Horizon Pharma Ireland Ltd

Published 2018

Canadian Agency for Drugs and Technologies in Health

89
90
91
92
93
94
95
96
97
98
99